Mednet Logo

Would you initiate chemoimmunotherapy (e.g. RCHOP) in a symptomatic patient with DLBCL who tested positive for COVID19?

1 Answer
Mednet Member
Mednet MemberInvited Expert
Hematology · UMass Chan Medical School
Answered on

It will depend on if he is symptomatic from covid infection or just positive but asymptomatic.

If asymptomatic from covid, I would treat. DLBCL is the one which is symptomatic and active disease without treatment is equally immunosuppressive. I would suggest giving rituximab with cycle 2 rather than...

Join for free or sign in to see the full answer